0001209191-23-001924.txt : 20230105
0001209191-23-001924.hdr.sgml : 20230105
20230105170030
ACCESSION NUMBER: 0001209191-23-001924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowenthal Richard E
CENTRAL INDEX KEY: 0001378550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 23512282
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001378550
Lowenthal Richard E
C/O ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
1
1
1
0
President and CEO
Stock option (right to buy)
8.42
2023-01-03
4
A
0
1100000
0.00
A
2033-01-02
Common Stock
1100000
1100000
D
Stock option (right to buy)
8.42
2023-01-03
4
A
0
350000
0.00
A
2033-01-02
Common Stock
350000
350000
I
By spouse
25% of the shares subject to the option vest on January 1, 2024, and the remaining shares will vest monthly thereafter over three years.
/s/ Kathleen Scott, Attorney-in-Fact
2023-01-05